New therapy targets drinking identity to curb alcohol cravings
NCT ID NCT06985927
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study tests whether a short, four-session therapy program that helps people rethink their identity and memories related to drinking can reduce alcohol use and cravings. Sixty adults with alcohol use disorder will be randomly assigned to either receive this therapy plus usual care, or usual care alone. Researchers will track drinking habits and symptoms over six months to see if the therapy makes a difference.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
24 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 24 years old, men or women * Having a diagnosis of alcohol use disorder according to DSM-5 criteria * Being a native French speaker * Patients enrolled in the national healthcare insurance program * Consenting to participate to the study Exclusion Criteria: * A diagnosis of current non-stabilized psychiatric disorders according to DSM-5 criteria * The presence of another substance use disorder, except for tobacco dependence * The presence of any intellectual disability, of pervasive developmental disorders * The presence of any neurological disorder or any other disorder affecting the central nervous system including neurological complications of alcoholism * A sensorial impairment uncorrected (visual and/or hearing)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu Reims
RECRUITINGReims, 51092, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Investigating the Mu:Kappa opioid receptor imbalance in alcohol use disorder
- Identification of cellular and molecular mechanisms involved in the pathophysiology of alcohol use disorder by examination of cerebrospinal fluid
- Intravenous acetate as an adjunctive treatment for alcohol withdrawal in hospitalized patients
- Can a gentle brain current quiet alcohol cravings?
- Brain imaging may expose a shared marker in PTSD and alcohol addiction
- Could a seizure drug curb alcohol withdrawal in trauma wards?